News/November 21, 2026

Randomized trial shows keto diet reduces liver fat by 67% in obese adults — Evidence Review

Published in Cell Metabolism, by researchers from Washington University School of Medicine

Researched byConsensus— the AI search engine for science

Table of Contents

A new randomized controlled trial from Washington University School of Medicine found that a ketogenic diet led to greater reductions in liver fat and prediabetes prevalence compared to Mediterranean and low-fat diets, even when weight loss was similar. Related studies generally support the metabolic benefits of low-carbohydrate and ketogenic diets, though some note potential lipid profile changes and emphasize the need for longer-term data.

  • Multiple meta-analyses and clinical trials report that low-carbohydrate or ketogenic diets often produce greater improvements in insulin resistance, liver fat, and weight loss than low-fat diets, especially in people with metabolic dysfunction or fatty liver disease 1 2 3 7.
  • Some research highlights potential increases in LDL cholesterol with ketogenic diets, raising questions about long-term cardiovascular effects, though short-term studies often find no adverse changes in overall cardiovascular risk markers 8 12 13 15.
  • Studies consistently note the importance of diet composition beyond calorie restriction, with evidence that macronutrient content can alter metabolic outcomes even when weight loss is matched across groups 1 7 8.

Study Overview and Key Findings

Nonalcoholic fatty liver disease and prediabetes are increasingly common conditions linked to obesity and metabolic syndrome. While weight loss is a cornerstone of management, the optimal dietary approach for improving liver health and glycemic status remains debated. This new trial addresses a key question: Does the type of diet, beyond its effect on weight, influence metabolic health—particularly liver fat content and prediabetes status? By strictly controlling calorie intake and providing all meals, the study isolates the effects of diet composition while minimizing confounding from differences in weight loss or adherence.

Property Value
Organization Washington University School of Medicine
Journal Name Cell Metabolism
Authors Samuel Klein, Max Petersen
Population Adults with obesity, prediabetes, and fatty liver disease
Sample Size 42 participants
Methods Randomized Controlled Trial (RCT)
Outcome Liver fat reduction, prediabetes status
Results Keto diet reduced liver fat by 67% and half no longer had prediabetes

To assess how these findings align with the broader scientific literature, we searched the Consensus database of over 200 million research papers. The following queries were used to identify relevant studies:

  1. keto diet liver fat reduction
  2. keto diet prediabetes outcomes
  3. low-carb diets health effects
Topic Key Findings
Do low-carbohydrate/ketogenic diets improve liver fat and metabolic health? - Both short-term and longer-term RCTs and meta-analyses show that low-carbohydrate and ketogenic diets can significantly reduce liver fat, visceral adiposity, and improve markers of insulin resistance, sometimes beyond what is achieved with low-fat diets 1 2 3 5 7.
- Some studies suggest that liver fat reduction and metabolic benefits may occur independently of weight loss, likely due to changes in hormonal and mitochondrial pathways 3 5.
How do low-carbohydrate/ketogenic diets affect glycemic control and prediabetes outcomes? - Ketogenic diets are associated with greater reductions in HbA1c and improved glycemic control in people with prediabetes or type 2 diabetes compared to moderate- or low-fat diets in several RCTs and meta-analyses 6 7 9.
- Studies show that some individuals on ketogenic diets can reduce or discontinue diabetes medications and bring blood sugar levels below the prediabetes threshold 6 7.
What are the cardiovascular and safety outcomes of low-carbohydrate diets? - Meta-analyses indicate that low-carbohydrate diets typically improve triglycerides and HDL cholesterol, but may increase LDL cholesterol in some individuals 12 13 15.
- Short-term studies generally find no significant adverse cardiovascular effects, though long-term safety and sustainability remain uncertain 8 12 14 15.
Does diet composition matter if weight loss is similar? - Evidence suggests that, even when weight loss is matched, low-carbohydrate diets may offer unique metabolic advantages, including improved insulin sensitivity and liver fat reduction, likely due to macronutrient-specific effects on hormones and substrate metabolism 1 3 7 8.
- The sustainability and nutrient adequacy of very low-carb diets require further evaluation 8 14.

Do low-carbohydrate/ketogenic diets improve liver fat and metabolic health?

Several randomized controlled trials and meta-analyses report that low-carbohydrate and ketogenic diets can significantly reduce liver fat and improve markers of insulin resistance, especially in people with obesity and fatty liver disease. These benefits are sometimes observed even when weight loss is similar between diet groups, suggesting additional mechanisms beyond calorie restriction.

  • Multiple studies find that ketogenic diets produce greater reductions in liver fat compared to standard low-fat or Mediterranean diets, supporting the new study's results 1 2 3 5 7.
  • Both short-term and 12-week interventions show that liver fat reduction can be rapid and substantial, with mechanisms potentially involving enhanced ketogenesis and changes in hepatic mitochondrial metabolism 3 5.
  • Meta-analyses confirm improvements in anthropometric measures and insulin resistance, with some evidence for improvements in liver enzymes 1 7.
  • The relationship between dietary saturated fat and cholesterol outcomes remains complex, but short-term trials often do not show adverse effects from increased fat intake 5 12.

How do low-carbohydrate/ketogenic diets affect glycemic control and prediabetes outcomes?

Evidence from RCTs and systematic reviews indicates that ketogenic diets may offer superior glycemic control compared to moderate carbohydrate or low-fat diets, particularly in people with prediabetes or type 2 diabetes. Some studies report a significant proportion of participants achieving normalization of blood sugar levels or reducing medication use.

  • Ketogenic and very low-carbohydrate diets are associated with greater reductions in HbA1c, improved insulin sensitivity, and more frequent diabetes medication discontinuation compared to standard diets 6 7 9.
  • Some trials observed that a substantial percentage of participants with prediabetes on ketogenic diets no longer met diagnostic criteria after intervention periods, aligning with the new study's findings 6.
  • Acute nutritional ketosis (e.g., via ketone supplementation) also demonstrates glucose-lowering effects in prediabetic individuals 10.
  • The magnitude and durability of these effects over the long term are less well studied 9 14.

What are the cardiovascular and safety outcomes of low-carbohydrate diets?

Research on the cardiovascular effects of low-carbohydrate and ketogenic diets is mixed. While these diets often improve triglyceride and HDL cholesterol levels, some studies report increases in LDL cholesterol, highlighting the need for careful consideration of individual risk factors and longer-term data.

  • Meta-analyses and systematic reviews report that low-carbohydrate diets lead to significant reductions in triglycerides and increases in HDL cholesterol, but may raise LDL cholesterol, especially with higher saturated fat intake 12 13 15.
  • Short-term RCTs often find no increase in overall cardiovascular risk markers or adverse events, though some individuals may experience mild gastrointestinal symptoms or adherence challenges 1 8 12.
  • Long-term effects on cardiovascular morbidity and mortality remain unclear due to limited follow-up in most trials 14 15.
  • Nutrient adequacy and sustainability are highlighted as important considerations, with possible reductions in fiber and micronutrient intake in very low-carb diets 8 14.

Does diet composition matter if weight loss is similar?

A growing body of evidence indicates that the macronutrient composition of a diet may influence metabolic outcomes independently of weight loss. Even when calorie intake and weight reduction are matched, diets with different macronutrient profiles can yield distinct effects on liver fat, insulin sensitivity, and other markers.

  • Controlled feeding studies and meta-analyses show that low-carbohydrate diets can improve insulin resistance and liver fat more than low-fat diets, even with similar weight loss, likely due to effects on hormones such as insulin and glucagon 1 3 7 8.
  • The new study's design, which matched weight loss across groups, strengthens the evidence for diet composition as an independent factor in metabolic health 1 3 7.
  • Sustainability and long-term adherence to very low-carbohydrate diets are commonly cited concerns, with some trials noting lower fiber and nutrient intake compared to Mediterranean or plant-forward diets 8 14.
  • Further research is needed to determine optimal macronutrient distributions for long-term health and disease prevention 14 15.

Future Research Questions

While this study adds to the evidence that low-carbohydrate and ketogenic diets may offer metabolic benefits beyond weight loss, important questions remain. Further research is needed to assess the long-term safety, sustainability, and broader applicability of these dietary patterns, as well as their effects in diverse populations and real-world settings.

Research Question Relevance
What are the long-term effects of ketogenic diets on liver fat and metabolic health? Long-term data are limited, and extended follow-up is needed to determine whether benefits persist or if adverse effects emerge 12 14 15.
How do ketogenic diets compare to Mediterranean and plant-based diets in sustainability and nutrient adequacy? Adherence, nutrient intake, and long-term sustainability remain concerns for very low-carbohydrate diets compared to other dietary patterns 8 14.
What are the cardiovascular outcomes of long-term ketogenic diets in diverse populations? While short-term studies report mixed effects on cholesterol profiles, the impact on cardiovascular events and mortality is still unclear 13 14 15.
Can individualized macronutrient targets optimize metabolic health for patients with prediabetes or NAFLD? Personalized nutrition approaches may maximize benefits and reduce risks, but more research is needed to guide individualized recommendations 1 14.
How do GLP-1 medications and dietary composition interact in the management of obesity and metabolic disease? New pharmacotherapies may alter dietary needs or enhance benefits, making it important to study combined effects in clinical practice 8.

Sources